EORTC General Assembly

2006-2009: Members

The General Assembly of the EORTC is comprised of effective members (voting and non-voting).


EFFECTIVE VOTING MEMBERS

Acting President:

M. Piccart, Brussels (BE)

   

Past Presidents (last three):

A.M.M. Eggermont, Rotterdam (NL)

 

A.T. van Oosterom, Leuven (BE)

 

J.-C. Horiot, Dijon (FR)

 

EORTC Group Chairs

Brain Tumour Group

M. J. van den Bent, Rotterdam (NL)

Breast Cancer Group

H. Bonnefoi, Bordeaux (FR)

Children's Leukemia Group

Y. Bertrand, Lyon (FR)

Gastrointestinal Tract Cancer Group

M. Lutz, Saarbrücken (DE)

Genito-Urinary Cancer Group

T. de Reijke, Amsterdam (NL)

Gynecological Cancer Group

N. Reed, Glasgow (GB)

Head and Neck Cancer Group

J. Vermorken, Antwerp (BE)

Infectious Diseases Group

J. Maertens, Leuven (BE)

Leukemia Group

T. de Witte, Nijmegen (NL)

Lung Cancer Group

P. Baas, Amsterdam (NL)

Lymphoma Group

R.W.M. Van Der Maazen, Nijmegen (NL)

Melanoma Group

A. Spatz,Villejuif (FR)

Pathobiology Group

M. Schmitt, Munich (DE)

Pharmacology and Molecular Mechanisms

N. Zaffaroni, Milan (IT)

Quality of Life Group

N. Aaronson, Amsterdam (NL)

Radiation Oncology Group

K. Haustermans, Leuven (BE)

Soft Tissue and Bone Sarcoma Group

J.Y. Blay, Lyon (FR)

 

EORTC Task Force Chairs

Cancer in the Elderly

U. Wedding, Jena (DE)

Cutaneous Lymphoma

S. Whittaker, London (GB)

 

EORTC Committee / Division Chairs

Clinical Research Division

R. Stupp, Lausanne (CH)

Laboratory Research Division

F. Sweep, Nijmegen (NL)

Independent Data Monitoring Committee

R. Kaplan, Leeds (GB)

Membership Committee

A.T. van Oosterom, Leuven (BE)

New Drug Advisory Committee

D. Cameron, Leeds (GB)

Protocol Review Committee

O. S. Nielsen, Aarhus (DK)

Translational Research Advisory Committee

F. Sweep, Nijmegen (NL)

Quality Assurance Committee

T. de Witte, Nijmegen (NL)

Scientific Audit Committee

J.-C. Horiot, Dijon (FR)

Representatives from the 15 Academic Recruiting

Institutions

University Medical Center, Nijmegen (NL)

T. de Witte

UZ Leuven, Leuven (BE)

P. Schöffski

Arnhems Radiotherapeutisch Instituut, Arnhem /Harderwijk (NL)

R. Keus

UZ Rotterdam, Rotterdam (NL)

R. de Wit

Maria Sklodowska - Curie Cancer Center, Warsaw (PL)

W. Ruka

Hopitaux Universitaires Bordet-Erasme, Brussels (BE)

A. Awada

The Netherlands Cancer Institute, Amsterdam (NL)

E. Rutgers

Institut Gustave Roussy, Villejuif (FR)

G. Vassal

Leiden University Medical Centre, Leiden (BE)

C. van de Velde

Academisch Medisch Centrum, Amsterdam( NL)

G. van Tienhoven

Institut Bergonie, Bordeaux (FR)

L. Mauriac

Universiteit Gent, Gent (BE)

J. van Meerbeeck

Western Infirmary, Glasgow (GB)

N. Reed

Charité, Berlin (DE)

V. Budach

St. James' University Hospital, Leeds (GB)

A. Kiltie

 

General Assembly Effective Non-Voting Members

Board Members (GA Effective Non Voting Members)

Vice-President

T. Tursz, Villejuif (FR)

Secretary General

P.Schöffski, Leuven (BE)

Treasurer

C. Sternberg, Roma (IT)

Member

M. Aapro, Genolier (CH)

Member

T. Cufer, Ljubljana (SI)

Member

P. Hohenberger, Mannheim (DE)

Member

J. Jassem, Gdanks (PL)

Member

I. Judson, London (GB)

Member

A. Spatz, Villejuif (FR)

Member

H. van Poppel, Leuven (BE)

 

Other Effective (GA Non Voting Members)

Director General, EORTC

F. Meunier, Brussels (BE)

Chairman, The EORTC Charitable Trust

Sir Christopher Mallaby, London (GB)

Editor-in-Chief, European Journal of Cancer

J.F. Smyth, Edinburgh (GB)

OECI President

U. Ringborg, Stockholm (SE)

EJC Liaison Officer

J-C. Horiot, Dijon (FR)

Executive Secretary, The EORTC Charitable Trust

V. Agnew, London (GB)

European Programmes Manager, US-NCI Liaison Office

S. Radtke, Brussels (BE)


Past Presidents

L. Denis (BE)

S. Garattini (IT)

G. Mathe (FR)

J. G. Mc Vie (GB)

D. van Bekkum (NL)

U. Veronesi (IT)